Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial (Q30788622)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial |
scientific article |
Statements
1 reference
Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial (English)
1 reference
Jean-Louis Vincent
1 reference
Gordon R Bernard
1 reference
Jan Bakker
1 reference
Jean-François Dhainaut
1 reference
Pierre-François Laterre
1 reference
Jonathan M Janes
1 reference
Antonio Artigas
1 reference
Hanno Riess
1 reference
Bruce R Basson
1 reference
Julien Charpentier
1 reference
Barbara G Utterback
1 reference
Recombinant Human Activated Protein C Worldwide Evaluation in Sepsis (PROWESS) Study Group
1 reference
24 April 2003
1 reference
1 reference
29
1 reference
894-903
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference